NewYorkBio/NYSE Emerging Biotech Company Showcase

Patient insights to shape development of a dCBT for IPF patients

Idiopathic Pulmonary Fibrosis (IPF) – weathering the pandemic

C21 shows promise against COVID-19 where other drugs have failed

Report on the ATTRACT study

Idiopathic Pulmonary Fibrosis: 5 Things to Know